Similar articles

• Epidemiology and inheritance of malignant hyperthermia.

  Kalow W, Britt BA, Chan FY. Kalow W, et al. Int Anesthesiol Clin. 1979 Winter;17(4):119-39. doi: 10.1097/00004311-197917040-00008. Int Anesthesiol Clin. 1979. PMID: 391720 Review. No abstract available.
• Diagnosis of susceptibility to malignant hyperthermia in man.

  Ording H. Ording H. Br J Anaesth. 1988 Feb;60(3):287-302. doi: 10.1093/bja/60.3.287. Br J Anaesth. 1988. PMID: 3279989 Review. No abstract available.
• Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?

  Nelson TE, Flewellen EH. Nelson TE, et al. Can Anaesth Soc J. 1979 Nov;26(6):484-8. doi: 10.1007/BF03006162. Can Anaesth Soc J. 1979. PMID: 526874
• The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

  Britt BA, Endrenyi L, Kalow W, Peters PL. Britt BA, et al. Can Anaesth Soc J. 1976 Nov;23(6):624-35. doi: 10.1007/BF03006745. Can Anaesth Soc J. 1976. PMID: 990979
• Muscle contractures and adenosine triphosphate depletion in porcine malignant hyperthermia.

  Gronert GA. Gronert GA. Anesth Analg. 1979 Sep-Oct;58(5):367-71. doi: 10.1213/00000539-197909000-00004. Anesth Analg. 1979. PMID: 573559